Evidence map›Paper›PMID 30075362›Full record

ArticleCarbohydrate research2018

Synthesis of high-mannose oligosaccharides containing mannose-6-phosphate residues using regioselective glycosylation.

Bo Meng, Jun Wang, Quanli Wang, Anthony S Serianni, Qingfeng Pan

Abstract read
In one paragraph

Article in Carbohydrate research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Bo MengOmicron Biochemicals, Inc., 115 South Hill Street, South Bend, IN, 46617-2701, USA.
Jun WangOmicron Biochemicals, Inc., 115 South Hill Street, South Bend, IN, 46617-2701, USA.
Quanli WangOmicron Biochemicals, Inc., 115 South Hill Street, South Bend, IN, 46617-2701, USA.
Anthony S SerianniOmicron Biochemicals, Inc., 115 South Hill Street, South Bend, IN, 46617-2701, USA; Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, IN, 46556-5670, USA.
Qingfeng PanOmicron Biochemicals, Inc., 115 South Hill Street, South Bend, IN, 46617-2701, USA. Electronic address: qpan@omicronbio.com.
Omron (Japan) · JPUniversity of Notre Dame · US

Funding

NCI NIH HHS HHSN261201500020C
6 · The paper itself

Abstract

Molecular recognition of mannose-6-phosphate (M6P)-modified oligosaccharides by transmembrane M6P receptors is a key signaling event in lysosomal protein trafficking in vivo. Access to M6P-containing high-mannose N-glycans is essential to achieving a thorough understanding of the M6P ligand-receptor recognition process. Herein we report the application of a versatile and reliable chemical strategy to prepare asymmetric di-antennary M6P-tagged high-mannose oligosaccharides in >20% overall yield and in high purity (>98%). Regioselective chemical glycosylation coupled with effective phosphorylation and product purification protocols were applied to rapidly assemble these oligosaccharides. The development of this synthetic strategy simplifies the preparation of M6P-tagged high-mannose oligosaccharides, which will improve access to these compounds to study their structures and biological functions.

Indexed as

Carbohydrate ConformationGlycosylationMannoseMannosephosphatesOligosaccharidesStereoisomerismMannosemannose-6-phosphateMannosephosphatesOligosaccharidesGlycosylationMannnose-6-phosphateOligosaccharideRegioselective

Identifiers

PMID30075362
PMCPMC6121786
OpenAlexW2886554621

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.